Evidence map›Paper›PMID 34131433›Full record

ArticleBiomedical signal processing and control2021

Automated detection of Covid-19 disease using deep fused features from chest radiography images.

Emine Uçar, Ümit Atila, Murat Uçar, Kemal Akyol

Abstract read
In one paragraph

Article in Biomedical signal processing and control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Emine UçarDepartment of Management Information Systems, Faculty of Business and Management Science, Iskenderun Technical University, Hatay, Turkey.
Ümit AtilaDepartment of Computer Engineering, Faculty of Engineering, Gazi University, Ankara, Turkey.
Murat UçarDepartment of Management Information Systems, Faculty of Business and Management Science, Iskenderun Technical University, Hatay, Turkey.
Kemal AkyolDepartment of Computer Engineering, Faculty of Engineering and Architecture, Kastamonu University, Kastamonu, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The health systems of many countries are desperate in the face of Covid-19, which has become a pandemic worldwide and caused the death of hundreds of thousands of people. In order to keep Covid-19, which has a very high propagation rate, under control, it is necessary to develop faster, low-cost and highly accurate methods, rather than a costly Polymerase Chain Reaction test that can yield results in a few hours. In this study, a deep learning-based approach that can detect Covid-19 quickly and with high accuracy on X-ray images, which are common in every hospital and can be obtained at low cost, was proposed. Deep features were extracted from X-Ray images in RGB, CIE Lab and RGB CIE color spaces using DenseNet121 and EfficientNet B0 pre-trained deep learning architectures and then obtained features were fed into a two-stage classifier approach. Each of the classifiers in the proposed approach performed binary classification. In the first stage, healthy and infected samples were separated, and in the second stage, infected samples were detected as Covid-19 or pneumonia. In the experiments, Bi-LSTM network and well-known ensemble approaches such as Gradient Boosting, Random Forest and Extreme Gradient Boosting were used as the classifier model and it was seen that the Bi-LSTM network had a superior performance than other classifiers with 92.489% accuracy.

Indexed as

Automatic medical diagnosisBi-LSTMCovid-19Deep learningPneumoniaX-ray

Identifiers

PMID34131433
PMCPMC8192891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.